# Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma

> **NCT00006249** · PHASE3 · UNKNOWN · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 1258 (actual)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** pegylated interferon alfa
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00006249
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-06
- **Primary completion:** 2003-08
- **Final completion:** —
- **Target enrollment:** 1258 (ACTUAL)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006249, "Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00006249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*